These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29208654)

  • 1. Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes.
    Koska J; Saremi A; Howell S; Bahn G; De Courten B; Ginsberg H; Beisswenger PJ; Reaven PD;
    Diabetes Care; 2018 Mar; 41(3):570-576. PubMed ID: 29208654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.
    Saremi A; Howell S; Schwenke DC; Bahn G; Beisswenger PJ; Reaven PD;
    Diabetes Care; 2017 Apr; 40(4):591-598. PubMed ID: 28148544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL).
    Hanssen NM; Beulens JW; van Dieren S; Scheijen JL; van der A DL; Spijkerman AM; van der Schouw YT; Stehouwer CD; Schalkwijk CG
    Diabetes; 2015 Jan; 64(1):257-65. PubMed ID: 24848072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
    Hammes HP; Brownlee M; Lin J; Schleicher E; Bretzel RG
    Diabetologia; 1999 May; 42(5):603-7. PubMed ID: 10333054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
    Hanssen NMJ; Westerink J; Scheijen JLJM; van der Graaf Y; Stehouwer CDA; Schalkwijk CG;
    Diabetes Care; 2018 Aug; 41(8):1689-1695. PubMed ID: 29784769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study.
    Sveen KA; Karimé B; Jørum E; Mellgren SI; Fagerland MW; Monnier VM; Dahl-Jørgensen K; Hanssen KF
    Diabetes Care; 2013 Nov; 36(11):3712-7. PubMed ID: 24026557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus.
    Fosmark DS; Torjesen PA; Kilhovd BK; Berg TJ; Sandvik L; Hanssen KF; Agardh CD; Agardh E
    Metabolism; 2006 Feb; 55(2):232-6. PubMed ID: 16423631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies.
    Razquin C; Ruiz-Canela M; Clish CB; Li J; Toledo E; Dennis C; Liang L; Salas-Huetos A; Pierce KA; Guasch-Ferré M; Corella D; Ros E; Estruch R; Gómez-Gracia E; Fitó M; Lapetra J; Romaguera D; Alonso-Gómez A; Serra-Majem L; Salas-Salvadó J; Hu FB; Martínez-González MA
    Cardiovasc Diabetol; 2019 Nov; 18(1):151. PubMed ID: 31722714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma AGE and Oxidation Products, Renal Function, and Preeclampsia in Pregnant Women with Type 1 Diabetes: A Prospective Observational Study.
    Kelly CB; Karanchi H; Yu JY; Leyva MJ; Jenkins AJ; Nankervis AJ; Hanssen KF; Garg SK; Scardo JA; Hammad SM; Aston CE; Beisswenger PJ; Lyons TJ
    J Diabetes Res; 2023; 2023():8537693. PubMed ID: 37601831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.
    Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Wirtz JJJM; Kooman JP; Schalkwijk CG
    PLoS One; 2019; 14(8):e0221058. PubMed ID: 31408493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of dicarbonyl stress and advanced glycation endproducts in lifelong endurance athletes vs. sedentary controls.
    Maessen MFH; Schalkwijk CG; Verheggen RJHM; Aengevaeren VL; Hopman MTE; Eijsvogels TMH
    J Sci Med Sport; 2017 Oct; 20(10):921-926. PubMed ID: 28416154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes.
    Kilhovd BK; Giardino I; Torjesen PA; Birkeland KI; Berg TJ; Thornalley PJ; Brownlee M; Hanssen KF
    Metabolism; 2003 Feb; 52(2):163-7. PubMed ID: 12601626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults.
    Kizer JR; Benkeser D; Arnold AM; Ix JH; Mukamal KJ; Djousse L; Tracy RP; Siscovick DS; Psaty BM; Zieman SJ
    Atherosclerosis; 2014 Jul; 235(1):116-21. PubMed ID: 24825341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults.
    Semba RD; Bandinelli S; Sun K; Guralnik JM; Ferrucci L
    J Am Geriatr Soc; 2009 Oct; 57(10):1874-80. PubMed ID: 19682127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
    Nin JW; Jorsal A; Ferreira I; Schalkwijk CG; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
    Diabetes Care; 2011 Feb; 34(2):442-7. PubMed ID: 21270199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes.
    Saulnier PJ; Wheelock KM; Howell S; Weil EJ; Tanamas SK; Knowler WC; Lemley KV; Mauer M; Yee B; Nelson RG; Beisswenger PJ
    Diabetes; 2016 Dec; 65(12):3744-3753. PubMed ID: 27609106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial.
    Houjeghani S; Kheirouri S; Faraji E; Jafarabadi MA
    Nutr Res; 2018 Jan; 49():96-106. PubMed ID: 29420997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
    Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
    Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
    Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
    J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes.
    Adeshara K; Gordin D; Antikainen AA; Harjutsalo V; Sandholm N; Lehto MJ; Groop PH;
    Cardiovasc Diabetol; 2024 Jul; 23(1):235. PubMed ID: 38965604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.